Top news from MedWatch this week
![Photo: MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12791283.ece/ALTERNATES/schema-16_9/doc7eok1wt4jdl13ye5emaw.jpg)
Monday
Layoffs dent Leo Pharma’s reputation among life science employees
Over-the-counter hearing aids behind 1% of first-quarter sales in US
Tuesday
Firing of Demant executive raises more questions than answers, says communications advisor
FDA rejects Ascendis Pharma drug
Wednesday
Demant stays mute on leadership layoffs: ”We have issues and we’re dealing with it”
Demant CEO: Prognosis held back by uncertainty about momentum’s duration
Thursday
Novo Nordisk expects Wegovy limits to last ”some months”
High demand makes Novo Nordisk hit the brakes on Wegovy
Key products continue to grow in Novo Nordisk’s first quarter
Friday
Novo Nordisk’s fastest launch ever was too fast to scale, CFO reflects on facing obstacles
Blackstone is using AI to control diabetes and slash spending on drugs